E-LIB Suche - Ergebnisse für: Thomas Yau

1

Adverse events associated with the delivery of telerehabili..:

Yau, Thomas ; McIntyre, McKyla ; Chan, Josh...
PLOS ONE. 19 (2024) 2 - p. e0297908 , 2024

Link: https://doi.org/10.1371/..

2

A phase Ib/II trial of capmatinib plus spartalizumab vs. sp..:

Santoro, Armando ; Assenat, Eric ; Yau, Thomas...
JHEP Reports. 6 (2024) 4 - p. 101021 , 2024

Link: https://doi.org/10.1016/..

3

Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and C..:

Bishnoi, Sarwan ; Kotasek, Dusan ; Aghmesheh, Morteza...
Cancer. 130 (2024) 11 - p. 1991-2002 , 2024

Link: https://doi.org/10.1002/..

4

Evolution of systemic therapy for advanced HCC patients: Di..:

Wong, Jeffrey Sum Lung ; Leung, Roland ; Cheung, Tan To.
Hepatology Communications. 7 (2023) 6 - p. , 2023

Link: https://doi.org/10.1097/..

5

Rational design of a booster vaccine against COVID-19 based..:

Hu, Ye-Fan ; Yuen, Terrence Tsz-Tai ; Gong, Hua-Rui...
Cell Host & Microbe. 31 (2023) 8 - p. 1301-1316.e8 , 2023

Link: https://doi.org/10.1016/..

6

Multimodal integrative genomics and pathology analyses in n..:

Cheung, Tan-to ; Ho, Daniel ; Lyu, Shirley...
Journal of Hepatology. 78 (2023) - p. S51-S52 , 2023

Link: https://doi.org/10.1016/..

7

Family-Specific Training Improves Linear B Cell Epitope Pre..:

Liu, Ran ; Hu, Ye-Fan ; Du, Jin...
IEEE/ACM Transactions on Computational Biology and Bioinformatics. 20 (2023) 6 - p. 3669-3680 , 2023

Link: https://doi.org/10.1109/..

8

Pembrolizumab as Second-Line Therapy for Advanced Hepatocel..:

Merle, Philippe ; Kudo, Masatoshi ; Edeline, Julien...
Liver Cancer. 12 (2023) 4 - p. 309-320 , 2023

Link: https://doi.org/10.1159/..

9

Recommendations of the International Society of Geriatric O..:

Rembielak, Agata ; Yau, Thomas ; Akagunduz, Baran...
Journal of Geriatric Oncology. 14 (2023) 4 - p. 101502 , 2023

Link: https://doi.org/10.1016/..

10

Phase I/Ib, open-label, multicenter, dose-escalation study ..:

Bauer, Todd M ; Santoro, Armando ; Lin, Chia-Chi...
Journal for ImmunoTherapy of Cancer. 11 (2023) 11 - p. e007353 , 2023

Link: https://doi.org/10.1136/..

11

Exposure‐response analysis for nivolumab plus ipilimumab co..:

Sangro, Bruno ; Yau, Thomas ; El‐Khoueiry, Anthony B....
Clinical and Translational Science. 16 (2023) 8 - p. 1445-1457 , 2023

Link: https://doi.org/10.1111/..

12

Trial watch: immunotherapeutic strategies on the horizon fo..:

Koh, Benjamin ; Tan, Darren Jun Hao ; Lim, Wen Hui...
OncoImmunology. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

13

Pembrolizumab in combination with gemcitabine and cisplatin..:

Kelley, Robin Kate ; Ueno, Makoto ; Yoo, Changhoon...
The Lancet. 401 (2023) 10391 - p. 1853-1865 , 2023

Link: https://doi.org/10.1016/..

14

Plain language summary of the HIMALAYA study: tremelimumab ..:

Abou-Alfa, Ghassan K ; Lau, George ; Kudo, Masatoshi...
Future Oncology. 19 (2023) 38 - p. 2505-2516 , 2023

Link: https://doi.org/10.2217/..

15

Predictive and Prognostic Potential of Liver Function Asses..:

Vogel, Arndt ; Kelley, Robin K. ; Johnson, Philip...
Liver Cancer. 12 (2023) 4 - p. 372-391 , 2023

Link: https://doi.org/10.1159/..